Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialEugenio Mercuri, A. Nascimento, Nathalie Goemans et al.|The Lancet Neurology|2024Cited by 128
Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History ComparisonsCraig M. McDonald, Michela Guglieri, Dragana Vučinić et al.|Annals of Clinical and Translational Neurology|2025Cited by 12
Givinostat in Duchenne Muscular Dystrophy: Natural history comparison applying propensity score matchingDavid Gómez‐Andrés, P. Bettica, Mercedes López Lobato et al.|Nervenheilkunde|2025Cited by 0